Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 12.60 as of Tuesday, July 28, 2026.
Forward PE Ratio (12.60) = Close Price ($166.34) / Consensus Forward EPS ($12.61)
FORWARD PE RATIO
12.60
SECTOR MEDIAN · HEALTHCARE
18.59
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-32.24%
vs the sector median at left
Becton, Dickinson and Company
Market Cap
$60.26B
Forward PE Ratio
12.60
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Becton, Dickinson and Company (BDX) | $60.26B | 12.60 |
| Cencora, Inc. (COR)vs › | $62.18B | 17.50 |
| Cardinal Health, Inc. (CAH)vs › | $54.46B | 21.28 |
| Boston Scientific Corporation (BSX)vs › | $68.46B | 13.56 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $71.62B | 14.58 |
| Edwards Lifesciences Corporation (EW)vs › | $48.18B | 27.66 |
| Humana Inc. (HUM)vs › | $46.67B | 42.42 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.93B | 37.97 |
| Cigna Corporation (CI)vs › | $79.64B | 9.55 |
| IQVIA Holdings Inc. (IQV)vs › | $40.61B | 16.64 |
Trailing P/E
40.2
reported TTM EPS
Forward P/E
12.6
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $12.61 implies +219.2% EPS growth vs the reported trailing $3.95.
At today's $166.34 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-09-30 | $12.61 | $12.32 – $12.69 | 7 | 13.2x |
| 2027-09-30 | $13.44 | $13.00 – $14.19 | 8 | 12.4x |
| 2028-09-30 | $14.33 | $14.15 – $14.78 | 1 | 11.6x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
